My name is Fumiko Chino and I'm a treating Radiation Oncologist at Memorial Sloan-Kettering Cancer Center in New York City. I specialize in the treatment of breast and gynecological cancers. I have a research focus on access, affordability, and equity in cancer care, particularly on the financial toxicity of cancer care. Financial toxicity refers to the costs borne by patients and the negative impacts on their lives, such as the ability to afford treatments, sacrifices made by patients and their families, and sometimes severe consequences like increased symptoms, uncontrolled disease, and even death. Patients often make significant sacrifices to afford their care, including going into bankruptcy or losing their homes, which can lead to generational poverty. This concept is not limited to cancer; other expensive health conditions like asthma and diabetes also cause financial strain. At ASCO, the world's leading oncology conference, one of the evolving research topics is the administrative burden placed on patients. Cancer patients, while dealing with treatment and side effects, also face complex and costly administrative tasks like filing for disability, filling out FMLA paperwork, and making insurance appeals. These tasks add stress and anxiety and can create barriers to care, leading to delays or skipped treatments, worsening patient outcomes. Our focus is on improving patient outcomes and making the cancer experience better. At ASCO, 40,000 oncologists and providers gather to identify new treatments and care delivery plans, with a growing focus on patient-centered care. This means ensuring patients not only survive cancer but thrive after treatment. This approach should extend to all aspects of medicine, focusing on what truly makes patients' lives longer and better.